Redbiotec sells CMV program to Pfizer Schlieren, Zurich, Switzerland[removed]Privately held Swiss Biopharmaceutical Company Redbiotec based in Zurich-Schlieren recently announced that it has sold Redvax GmbH, a spin-of - Zurich Cantonal Bank - Document - PDFSEARCH.IO

First Page	Meta Content
	Redbiotec sells CMV program to Pfizer Schlieren, Zurich, Switzerland[removed]Privately held Swiss Biopharmaceutical Company Redbiotec based in Zurich-Schlieren recently announced that it has sold Redvax GmbH, a spin-of Add to Reading List Document Date: 2015-01-11 09:20:52 Open Document File Size: 179,49 KB Share Result on Facebook City Zurich / / Company Zürcher Kantonalbank / Pfizer / Redvax GmbH / Redbiotec AG / / Country Switzerland / / Event Business Partnership / M&A / / IndustryTerm finance / / MedicalCondition disease / / Person Christian Schaub / Jürg F. Geigy / Erika Puyal / / Position Head of Start-up finance / CEO / Managing Director / / URL http / SocialTag Pfizer Cytomegalovirus vaccine Viral diseases Zurich Cantonal Bank Human cytomegalovirus Medicine Health Biology Vaccines Corporate crime

Redbiotec sells CMV program to Pfizer Schlieren, Zurich, Switzerland[removed]Privately held Swiss Biopharmaceutical Company Redbiotec based in Zurich-Schlieren recently announced that it has sold Redvax GmbH, a spin-ofAdd to Reading List